Aster DM Quality Care, one of India’s leading integrated healthcare providers, has reported a robust performance for the quarter ended June 30, 2026, with its combined proforma operations delivering strong growth across key financial and operational parameters.

 

The company reported a 20% year-on-year increase in revenue to Rs. 2,597 crore in Q1 FY27, while operating EBITDA rose 30% YoY to Rs. 576 crore. The operating EBITDA margin expanded by 170 basis points to 22.2%, reflecting improved operational efficiency and scale benefits following the merger.

 

Excluding Kasargod Hospital, operating EBITDA grew 31% YoY, with margins improving to 22.4%, up 190 basis points compared with the previous year. The company also highlighted that Kasargod Hospital achieved monthly EBITDA break-even within the ninth month of operations.

 

Aster DM Quality Care reported a ROCE of 22.9%, an improvement of 246 basis points YoY. The merger of Aster DM Healthcare and Quality Care became effective on July 1, 2026, creating a larger integrated healthcare platform.

 

Azad Moopen, Executive Chairman, said: "The coming together of Aster DM Quality Care marks a defining milestone in our nearly four-decade journey of building world-class healthcare institutions. We aspire to create one of India’s leading integrated healthcare platforms, bringing together Aster, CARE, KIMS India, and Evercare into a unified network with over 10,800 beds across 28 cities, positioning Aster Quality Care among the top three hospital chains in India. Over the coming years, we expect to expand this network to more than 15,000 beds.

 

"As we embark on this new chapter, our philosophy is simple: greater scale, greater clinical excellence, and greater impact. By combining exceptional medical talent with advanced technology, artificial intelligence, robotics, research, and innovation, we will redefine the future of healthcare delivery."

 

Commenting on the Q1 FY27 performance, Varun Khanna, Managing Director & Group CEO, said: "The recent merger and formation of Aster DM Quality Care, marks a significant moment for the companies, our patients, our doctors and clinical staff, and for the industry overall. In this new chapter we are committed to keeping our core and value system unchanged, with continued focus on patient care, enabling doctors and hospital operations through technology, and best-in-class clinical outcomes.

 

"Aster DM Quality Care on a combined proforma basis achieved a revenue of Rs. 2,597 crore, a growth of 20% YoY, with an EBITDA Margin expansion of +170 bps at 22.2%, on the back of an operating EBITDA increase of 30% to Rs. 576 crore. We had the privilege of serving 2 million people in our OP and IP in Q1 FY27, which is 13% more people than in the previous year. 

 

"Our focus in the coming quarters is on disciplined execution - enhancing patient care, unlocking the full potential of our combined platform, and driving long-term value through operational excellence.”

 

The Aster DM Healthcare business recorded a 22% YoY growth in revenue to Rs. 1,311 crore in Q1 FY27.

 

Key highlights include operating EBITDA, excluding Kasargod, increased 30% YoY to Rs. 279 crore. Normalised PAT, excluding Kasargod, increased 46% YoY to Rs. 131 crore.

Average Revenue Per Patient (ARPP) for in-patients rose 10% YoY to Rs. 1,30,352. Total patient volumes increased 16% YoY.

 

Mature hospitals reported 19% revenue growth YoY. Emerging hospitals recorded 95% revenue growth YoY. Quality Care also delivered strong momentum during the quarter, with revenue growing 19% YoY to Rs. 1,287 crore.

 

With the merger now complete, Aster DM Quality Care aims to leverage its expanded network, clinical expertise and technology capabilities to accelerate growth while strengthening its position in India’s healthcare sector.